Non-dietary methods in the treatment of celiac disease

about

Analysis of the concentration of vitamin E in erythrocytes of patients with celiac disease.Translational Chemistry Meets Gluten-Related Disorders.

P2860

Q37553673-B40679D0-0998-4853-9A6A-B5D7D93DDC1E Q52358106-21C630B2-EB4E-4065-97B5-9F26EF056E41

P2860

Non-dietary methods in the treatment of celiac disease

Item

http://www.wikidata.org/entity/Q26863359

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Non-dietary methods in the treatment of celiac disease

@ast

Non-dietary methods in the treatment of celiac disease

@en

Non-dietary methods in the treatment of celiac disease

@nl

type

Item

label

Non-dietary methods in the treatment of celiac disease

@ast

Non-dietary methods in the treatment of celiac disease

@en

Non-dietary methods in the treatment of celiac disease

@nl

prefLabel

Non-dietary methods in the treatment of celiac disease

@ast

Non-dietary methods in the treatment of celiac disease

@en

Non-dietary methods in the treatment of celiac disease

@nl

P1476

Non-dietary methods in the treatment of celiac disease

@en

P2093

Anna Szaflarska-Popławska

http://www.w3.org/2001/XMLSchema#string

P2860

Protein engineering of improved prolyl endopeptidases for celiac sprue therapy

Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques

Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial

Structural basis for gluten intolerance in celiac sprue

Systematic review: tolerable amount of gluten for people with coeliac disease.

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.

Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells.

P304

12-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4467846

http://www.w3.org/2001/XMLSchema#string

P356

10.5114/PG.2014.47503

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276148577

http://www.w3.org/2001/XMLSchema#string

P698

25960809

http://www.w3.org/2001/XMLSchema#string

P932

4411409

http://www.w3.org/2001/XMLSchema#string

Non-dietary methods in the treatment of celiac disease

about

P2860

P2860

Non-dietary methods in the treatment of celiac disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P577

P5875

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P577

P5875

P698

P932